1. DI Morton, D-R Wen, JH Wong, JS Economou, LA Cagle, FK Storm, LJ Foshag, AJ Cochran. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127:392-399, 1992.

2. OE Nieweg, BAE Kapteijn, JF Thompson, BBR Kroon. Lymphatic mapping and selective lymphadenectomy for melanoma: not yet standard therapy. Eur J Surg Oncol 23:397-398, 1997.

3. U Veronese J Adamus, DC Bandera, O Brtnnhwvn, E Caceres, N CascrnelM, F Claudio, RL Ikwnwpiswv, VV Javorski, S Kirov, A Kulakowski, J Lacour, F Le^ne, Z Mechl, A Mwrabitw, I Rode, S Strgttv, E Van S^oton, K Szczygiel, NN Trapezni-kov, RI Wagner. Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer 49:2420-2430, 1982.

4. AS Coates, CI Ingvar, K Petersen-Schaefer, HM Shaw, GW Milton, CJ O'Brien, JF Thompson, WH McCarthy. Elective lymph node dissection in patients with primary melanoma of the trunk and limbs treated at the Sydney Melanoma Unit from 1960 to 1991. J Am Coll Surg 180:402-409, 1995.

5. CM Balch, S-J Soong, AA Barto^cd, MM Urist, CP Korokousis, TJ Smith, WJ Temple, MI Ross, WR Jewell, MC Mihm, RL Bamhill, HJ Wofebo. Efficocn of an elective regiofol lymph node dissection of 1-4 mm thick melanomas for patients 60 years of age and younger. Ann Surg 224:255-266, 1996.

6. BBR Kroon, A Jonk. Elective lymph node dissection in melanoma: still a controversial issue. Neth J Surg 43:129-132, 1991.

7. CM Balch. The role of elective lymph node dissection in melanoma: Rationale, results, and coftroversies. J Clin Oncol 6:163-172, 1988.

8. N CascrnelM, A Moriboto, M Sontinomi, RM MacKfe, F Belli, on behalf of the WHO Melanoma Progromme. Immediote or delayed dissection of regional nodes in patients with melanoma of the trunk: A randomized trial. Lancet 351:793-796, 1998.

9. DL Morton. Management of regional lymph nodes in melanoma patients. Melanoma Res 7(Suppl 1):S22, 1997.

10. R Essner, DL Morton. Elective lymph node dissection. In: FJ Lejeune, PK Chaud-huri, TK Das Gupta, eds. Malignant Melanoma. Medical and Surgical Management. New York: McGraw-Hill, 1994, pp. 205-214.

11. E Joseph, D Ropoport, F Glass, J Messina, CW Cruse, C Berman, R Deconti, G Lyman, A Cantor, DS Reintgen. Generation of mathematical model to predict sentinel node involvement in malignant melanoma. Melanoma Res 7(Suppl 1):S78, 1997.

12. L Proner, H Winke^^r, N Gritzmann, F Winke^^r, M Helmer, H Pehomberger. Sonography versus palpation in the detection of regional lymph node metastases in patients with malignant melonomo. Eur J Cancer 26:827-830, 1990.

13. CR Rossi, A Seno, A Vecchioto, M Foletto, A ^g^ghi, A De Candfe, L Rubaltelli, C Montesco, M Lise. The impact of ultrasound scanning in the staging and follow-up of patients with clinical stage I cutaneous melanoma. Eur J Cancer 33:200-203, 1997.

14. MWM Van den Brekel, FA Pame^, W Koops, FJM Hilgers, BBR Kroon, AJM Balm. Computed tomography for the detection of neck node metastases in melanoma patients. Eur J Surg Oncol 24:51-54, 1998.

15. LM Lamki, AA Zukiwski, LJ Shanken, SS Legha, RS Benjamin, CE Plager, DF Salk, RW Schroff, JL Murray. Radio-imaging of melanoma using 99mTc-labeled Fab fragment reactive with a high molecular weight melanoma antigen. Cancer Res 50(Suppl):904-908, 1990.

16. DSB Hoon, Y Wang, PS Dale, AJ Conrad, P Schmid, D Garrison, Ch Kue, LJ Fos-hag, AJ Nizze, DL Morton. Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J Clin Oncol 13:2109-2116, 1995.

17. DSB Hoon, T Okamoto, C Kuo, AJ Conrad, P Schmid, DL Morton. Detection of metastatic melanoma in blood by multimarker RT-PCR: correlation to clinical stage and recurrence of disease. Melanoma Res 7(Suppl 1):S56, 1997.

18. X Wang, W Li, SC Shivers, DS Reintgen. Early detection of circulating melanoma cells in peripheral blood by RT-PCR. Melanoma Res 7(Suppl 1):S56, 1997.

19. EM Rankin, CM Korse, JMG Bonfrer. The prognostic value of circulating protein S-100ß in malignant melanoma patients. Melanoma Res 7(Suppl 1):S87, 1997.

20. JF Thompson, WH McCarthy, CMJ Bosch, CJ O'Brien, MJ Quinn, S Paramaes-varan, K Crotty, SW McCarthy, RF Uren, R Howman-Giles. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res 5:255-260, 1995.

21. DJ Krag, SJ Meijer, DL Weaver, BW Loggie, SP Harlow, KK Tanabe, EH Laughlin, JC Alex. Minimal access surgery for staging of malignant melanoma. Arch Surg 130:654-658, 1995.

22. BAE Kapteijn, OE Nieweg, IH Liem, WJ Mooi, AJM Balm, SH Muller, JL Peterse, RA Valdes Olmos, CA Hoefnagel, BBR Kroon. Localizing the sentinel node in cutaneous melanoma: gamma probe detection versus blue dye. Ann Surg Oncol 4: 156-160, 1997.

23. LF Glass, J Messina, J Glass, E Joseph, R Deconti, CW Cruse, D Rapaport, C Ber-man, N Fenske, DS Reintgen. The results of complete lymph node dissections in 88 melanoma patients with positive sentinel nodes. Melanoma Res 7(Suppl 1):S104, 1997.

24. A Barth, DL Morton. Role of adjuvant therapy in melanoma management. Cancer 75:726-734, 1995.

25. JM Kirkwood, JM Strawderman, MS Ernstoff, TJ Smith, EC Borden, TH Blum. Interferon-a.2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol 14:7-17, 1996.

26. DL Morton, LJ Foshag, DSB Hoon, JA Nizze, LA Wanek, PHC Chang, DG Dav-tyan, RK Gupta, R Elashoff, RF Irie. Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine. Ann Surg 216:463-482, 1992.

27. DS Reintgen, AJ Conrad. Detection of occult melanoma cells in sentinel lymph nodes and blood. Semin Oncol 24(Suppl 4):S4-11-S4-15, 1997.

28. W Li, SC Shivers, X Wang, E Joseph, DS Reintgen. RT-PCR of sentinel lymph node metastases in malignant melanoma patients. Melanoma Res 7(Suppl 1):S34, 1997.

29. BAE Kapteijn, OE Nieweg, RA Valdes Olmos, IH Liem, RKL Baidjnath Panday, CA Hoefnagel, BBR Kroon. Reproducibility of lymphoscintigraphy for lymphatic mapping in cutaneous melanoma. J Nucl Med 37:972-975, 1996.

30. BAE Kapteijn, OE Nieweg, SH Muller, IH Liem, CA Hoefnagel, EJTh Rutgers, BBR Kroon. Validation of gamma probe detection of the sentinel node in melanoma. J Nucl Med 38:362-366, 1977.

31. JJ Albertini, CW Cruse, D Rapaport, K Wells, M Ross, R DeConti, CG Berman, K Jared, J Messina, G Lyman, F Glass, N Fenske, DS Reintgen. Intraoperative radio-lymphoscintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 223:217-224, 1996.

32. P Sharkey, C Berman, DS Reintgen. Comparison of radiopharmaceuticals utilized in lymphoscintigraphy. Melanoma Res 7(Suppl 1):S87, 1997.

33. BAE Kapteijn, OE Nieweg, JL Peterse, EJTh Rutgers, BBR Kroon. Sequential lymphatic dissemination of breast cancer. Eur J Surg Oncol 22:399, 1996.

34. JJ Albertini, GH Lyman, Ch Cox, T Yeatman, L Balducci, N Ku, S Shivers, C

Berman, K Wells, D Rapaport, A Shons, J Horton, H Greenberg, S Nicosia, R Clark, A Cantor, DS Reintgen. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 276:1818-1822, 1996.

35. AE Giuliano, PS Dale, RR Turner, DL Morton, SW Evans, DL Krasne. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 222: 394-401, 1995.

36. R Pijpers, S Meijer, OS Hoekstra, GJ Collet, EFI Comans, RPA Boom, PJ Van Diest, GJJ Teule. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer. J Nucl Med 38:366-368, 1997.

37. U Veronesi, G Paganelli, V Galimberti, G Viale, S Zurrida, M Bedoni, A Costa, C De Cicco, JG Geraghty, A Luini, V Sacchini, P Veronesi. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 349:1864-1867, 1997.

38. PJ Borgstein, S Meijer, R Pijpers. Intradermal blue dye to identify sentinel lymph node in breast cancer. Lancet 349:1668-1669, 1997.

39. AE Giuliano. Intradermal blue dye to identify sentinel lymph node in breast cancer. Lancet 350:958, 1997.

40. OE Nieweg, J De Vries, L Jansen, H Schraffordt Koops, BBR Kroon. Sentinel node biopsy in breast cancer. Lancet 350:808, 1997.

41. CI Perre. Breast cancer diagnostic and staging aspects. Thesis. University of Amsterdam, 1996.

42. RJ Isaacs, JM Ford, SG Allan, GV Forgeson, S Gallagher. Role of computed tomography in the staging of primary breast cancer. Br J Surg 80:1137, 1993.

43. HT Turoglu, NA Janjan, MK Thorsen, KA Shaffer, PS Ritch, RM Hansen, AP Walker, M Gai, BD Collier. Imaging of regional spread of breast cancer by internal mammary lymphoscintigraphy, CT and MRI. Clin Nucl Med 17:482-484, 1992.

44. OE Nieweg, EE Kim, W-H Wong, WF Broussard, SE Singletary, GN Hortobagyi, RS Tilbury. Positron emission tomography with fluorine-18 deoxyglucose in the detection and staging of breast cancer. Cancer 71:3920-3925, 1993.

45. L Biassoni, M Granowska, MJ Caroll, F McNeill, R Howell, D Ellison, A Granow-ski, SJ Mather, RA Carpenter, KE Britton. Primary breast cancer: Tc-99m SM3, antistripped mucin core protein monoclonal antibody in assessment of axillary node involvement. Eur J Nucl Med 22:35, 1995.

46. CI Perre, JE Riitter, PA Vos, P De Hooge. Technetium-99-m-sestamibi uptake in axillary lymph node metastases in breast cancer patients. Eur J Surg Oncol 23:142144, 1997.

47. WL McGuire, GM Clark. Prognostic factors and treatment decisions in axillary node negative breast cancer. N Engl J Med 326:1756-1761, 1992.

48. L Jansen, OE Nieweg, RA Valdes Olmos, EJTh Rutgers, JL Peterse, J de Vries, MH Doting, BBR Kroon. Improved staging of breast cancer through lymphatic mapping and sentinel node biopsy: A case report. Eur J Surg Oncol 24:445-446, 1998.

49. BAE Kapteijn. Biopsy of the sentinel node in melanoma, penile carcinoma and breast carcinoma. The case for lymphatic mapping. Thesis. University of Amsterdam, 1997.

50. S Horenblas. Diagnosis and treatment of penile cancer, new strategies. Eur Urol Today 6:3-4, 1995.

51. RM Cabanas. An approach for the treatment of penile carcinoma. Cancer 39:456466, 1977.

52. C Levenback, TW Burke, M Morris, A Malpica, KR Lukas, DM Gershenson. Potential applications of intraoperative lymphatic mapping in vulvar cancer. Gynecol Oncol 59:216-220, 1995.

53. JJA Joosten, LJA Stroble, EDM Bruggink, CAP Wauters, M Pruszezynski, Th Wob-bes, TJM Ruers. Intraoperative lymphatic mapping and the sentinel node concept in colorectal cancer. Eur J Nucl Med 26(suppl):S74.

Was this article helpful?

0 0
How To Prevent Skin Cancer

How To Prevent Skin Cancer

Complete Guide to Preventing Skin Cancer. We all know enough to fear the name, just as we do the words tumor and malignant. But apart from that, most of us know very little at all about cancer, especially skin cancer in itself. If I were to ask you to tell me about skin cancer right now, what would you say? Apart from the fact that its a cancer on the skin, that is.

Get My Free Ebook

Post a comment